# Bax Pore Formation in Apoptosis: Structures of Intermediates and Mechanism of Assembly (Lin)

> **NIH NIH P20** · UNIVERSITY OF OKLAHOMA · 2021 · $233,993

## Abstract

Project Summary (Lin Project)
Apoptosis is a cell death program that normally eliminates dysfunctional cells, and hence is essential to human
health. Insufficient apoptosis leads to cancer, while excessive apoptosis worsens brain damage after stroke.
To develop effective treatments for these diseases we need a comprehensive understanding of how apoptosis
is regulated. Mitochondrial membrane perforation is the commitment step of apoptosis that is regulated by
interactions among the Bcl-2 family proteins, such as the pro-apoptotic Bax and the anti-apoptotic Bcl-2. While
anti-cancer drugs that selectively target and inhibit the anti-apoptotic proteins have shown promise in clinical
trials, limited structural information on the pro-apoptotic proteins has become a bottleneck for development of
neural protective agents that can reduce stroke damage. In particular, structures of active Bax oligomers that
can form giant pores in the mitochondrial membrane to release deadly mitochondrial factors are unknown.
Since native Bax proteins have multiple ways to interact and can generate different types of heterogeneous
oligomers that are not amenable to structure determination, an alternative and innovative experimental
approach is required to determine the structures of these different oligomers and the giant pores they can form.
We hypothesize that: (A) Homogeneous small oligomers suitable for structure determination can be created by
using truncated or mini-Bax proteins that retain key interacting regions seen in intact Bax oligomers; (B) These
small oligomers will be ideal tools to dissect the mechanism by which intact Bax proteins perforate the
mitochondrial membrane, and by which anti-apoptotic compounds target Bax to prevent this mitochondrial
leakage and neuronal cell death. Our project for the Oklahoma COBRE in Structural Biology Phase II
application will test our novel hypotheses in the following Specific Aims: (1) What are the structures of the mini-
Bax oligomers and how do they contribute to the giant pore assembly by intact Bax? (2) How do anti-apoptotic
compounds block Bax pore formation in the mitochondrial membrane? In Aim 1, we will use molecular biology
techniques to construct mini-Bax proteins. We will perform disulfide crosslinking experiments and size
exclusion chromatography to select the mini-oligomer forming proteins and a mitochondrial protein or liposomal
dye release assay will be used to identify the mini-pore forming oligomers. We will conduct crystallization trials
with the pore-forming, size-selected homogeneous mini-oligomers and solve their structures using X-ray
diffraction. If suitable crystals are not obtained, we will measure small-angle X-ray scattering of the mini-Bax
proteins in solution, detergent micelle, or lipid nanodisc to reveal the mini-oligomeric structures. Moreover, we
will use electron cryo-microscopy to reveal the mini-pore structures in membranes, and mutagenesis to assess
how these mini-structures contribute...

## Key facts

- **NIH application ID:** 10197149
- **Project number:** 5P20GM103640-10
- **Recipient organization:** UNIVERSITY OF OKLAHOMA
- **Principal Investigator:** JIALING LIN
- **Activity code:** P20 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $233,993
- **Award type:** 5
- **Project period:** 2012-08-01 → 2023-05-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10197149

## Citation

> US National Institutes of Health, RePORTER application 10197149, Bax Pore Formation in Apoptosis: Structures of Intermediates and Mechanism of Assembly (Lin) (5P20GM103640-10). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/10197149. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*
